Alpha 2.0
Login Register
» Authors » Alexandre Demoule

Alexandre Demoule

Explore the profile of Alexandre Demoule including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 246
Citations 6410
Followers 0
Related Specialties
Critical Care
Pulmonary Medicine
General Medicine
Top 10 Co-Authors
Thomas Similowski
Martin Dres
Elie Azoulay
Julien Mayaux
Maxens Decavele
Achille Kouatchet
Samir Jaber
Matthieu Schmidt
Virginie Lemiale
Djamel Mokart
Published In
Intensive Care Med
Ann Intensive Care
Crit Care
Am J Respir Crit Care Med
Anesthesiology
Affiliations
Soon will be listed here.
Recent Articles
1.
Response to "Relationships between dyspnea, oxygenation and prognosis in hypoxemic respiratory failure"
Demoule A, Baptiste A, Decavele M, Belin L, Frat J
Crit Care . 2025 Feb; 29(1):90. PMID: 40011945
No abstract available.
2.
Correction: Dyspnea is severe and associated with a higher intubation rate in de novo acute hypoxemic respiratory failure
Demoule A, Baptiste A, Thille A, Similowski T, Ragot S, Prat G, et al.
Crit Care . 2025 Feb; 29(1):89. PMID: 40011932
No abstract available.
3.
Management of severe exacerbations of COPD by French intensivists and adherence to guidelines
Haudebourg L, Faure M, Dres M, Roche N, Terzi N, Morawiec E, et al.
Respir Med Res . 2025 Feb; 87:101159. PMID: 39999616
Background: Severe exacerbations of chronic obstructive pulmonary disease (ECOPD) require hospitalization in intensive care unit (ICU) in 10 % of cases. This study aims to describe current practices for the...
4.
Previous treatment with anthracycline does not affect the course of sepsis in cancer patients: Retrospective cohort study
Windsor C, Joseph A, Pons S, Mokart D, Pene F, Kouatchet A, et al.
J Intensive Med . 2025 Jan; 5(1):64-69. PMID: 39872834
Background: Cancer patients who are exposed to sepsis and had previous chemotherapy may have increased severity. Among chemotherapeutic agents, anthracyclines have been associated with cardiac toxicity. Like other chemotherapeutic agents,...
5.
A multivariable prediction model for invasive pulmonary aspergillosis in immunocompromised patients with acute respiratory failure (IPA-GRRR-OH score)
Friol A, Dumas G, Pene F, Demoule A, Kouatchet A, Argaud L, et al.
Intensive Care Med . 2025 Jan; 51(1):72-81. PMID: 39853358
Purpose: Invasive pulmonary aspergillosis (IPA) is a life-threatening opportunistic infection in immunocompromised patients. The diagnosis is often made late, with mortality reaching 90% when mechanical ventilation is needed. We sought...
6.
The transition phase between controlled mechanical ventilation and weaning is our next great cause
Demoule A
Curr Opin Crit Care . 2025 Jan; 31(1):1-4. PMID: 39748796
No abstract available.
7.
Overcoming left diaphragm ultrasound challenges: exploring promising techniques
Hermans G, Demoule A, Heunks L
Intensive Care Med . 2024 Dec; 51(2):438-439. PMID: 39714618
No abstract available.
8.
Contribution and evolution of respiratory muscles function in weaning outcome of ventilator-dependent patients
Virolle S, Duceau B, Morawiec E, Fosse Q, Nierat M, Parfait M, et al.
Crit Care . 2024 Dec; 28(1):421. PMID: 39696360
Background: The present study was designed to investigate the evolution and the impact of respiratory muscles function and limb muscles strength on weaning success in prolonged weaning of tracheotomized patients....
9.
Nasal High Flow to Modulate Dyspnea in Orally Intubated Patients
Le Stang V, Graverot M, Kimmoun A, Nierat M, Decavele M, Similowski T, et al.
Am J Respir Crit Care Med . 2024 Dec; PMID: 39680951
Rationale: High flow therapy reduces dyspnea in acute respiratory failure but the underlying mechanisms are not fully elucidated. Objectives: To compare dyspnea, airway occlusion pressure (P) and inspiratory work with...
10.
Similar Kinetics of Pulmonary SARS-CoV-2 Load in Intensive Care Unit Patients with COVID-19 Pneumonia with or Without Autoantibodies Neutralizing Type I Interferons
Le Stang V, Bastard P, Langouet E, De Chambrun M, Chommeloux J, Gervais A, et al.
J Clin Immunol . 2024 Nov; 45(1):45. PMID: 39565497
Purpose: The pathogenesis of life-threatening coronavirus disease 2019 (COVID-19) pneumonia in ICU patients can involve pre-existing auto-antibodies (auto-Abs) neutralizing type I interferons (IFNs). The impact of these auto-Abs on SARS-CoV-2...